Main Line biopharma firm behind Covid-19 therapy raises $30M to advance product line

The Radnor company recently received its first regulatory approval for its Covid-19 treatment.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.